Publication | Closed Access
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
179
Citations
20
References
2018
Year
Metabolic SyndromeHypertensionCardiovascular DiseaseDapagliflozin EffectPharmacologyCardiovascular PharmacologyPharmacotherapyPreventive CardiologyMedicineCardiologyCardiovascular Events
| Year | Citations | |
|---|---|---|
Page 1
Page 1